Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06773715 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 14, 2025 (before its estimated December 19, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The goal of this randomized control clinical trial is to learn if virtual reality can be used to treat sickle cell pain in children. The main questions it aims to answer are: Does virtual reality reduce pain severity during a child's hospital stay for a vaso-occlusive pain crisis? Does virtual reality decrease the daily use of opiates? Researchers will compare standard therapy to the use of standard therapy plus a daily virtual reality experience to see if virtual reality works to treat sickle cell pain. All patients will: \- Be asked to fill out a pain assessment survey three times daily for up to 3 days If randomized to intervention arm, patients will: * Participate in an immersive virtual reality experience once daily for up to 3 days * Fill out a survey twice daily to monitor for side effects from virtual reality experience * Fill out a satisfaction survey once during the study period
Trial Details
NCT Number NCT06773715
Lead Sponsor Louisiana State University Health Sciences Center in New Orleans
Collaborators: KindVR
Conditions
(from sponsor)		 Sickle Cell Disease, Vaso-occlusive Pain Episodes
Related terms Anemia, Sickle Cell
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov